JBIO
Jade Biosciences
JBIO
JBIO
55 hedge funds and large institutions have $434M invested in Jade Biosciences in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
10% more capital invested
Capital invested by funds: $396M → $434M (+$38.7M)
0.14% more ownership
Funds ownership: 3.02% → 3.15% (+0.14%)
Holders
55
Holding in Top 10
7
Calls
–
Puts
–
Top Buyers
| 1 | +$9.95M | |
| 2 | +$4.04M | |
| 3 | +$3.32M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$2.49M |
| 5 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$1.41M |
Top Sellers
| 1 | -$5.15M | |
| 2 | -$3.06M | |
| 3 | -$1.82M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$1.5M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$331K |